About the Next-Generation Sequencing in Oncology Session
Next-generation sequencing (NGS) has become a cornerstone in oncology research, offering unprecedented insights into the molecular architecture of cancers. This advanced technology allows for a detailed examination of the genetic mutations, variations, and alterations that drive tumor growth. By sequencing the DNA or RNA of cancerous tissues, clinicians can identify specific mutations, enabling personalized treatment options tailored to the individual’s genetic makeup. NGS is also valuable in detecting rare genetic mutations that may not be visible with conventional methods, allowing for early diagnosis and more targeted therapies. As a result, it plays a crucial role in precision medicine, offering hope for more effective treatments and improved patient outcomes.
Topics Covered in Next-Generation Sequencing in Oncology
Targeted Gene Panels
Whole-Exome Sequencing
Transcriptome Profiling
Bioinformatics Pipelines
Variant Interpretation
Incidental Germline Findings
Related Scientific Sessions at CIOC 2027
Why Attend the Next-Generation Sequencing in Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Next-Generation Sequencing in Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Next-Generation Sequencing in Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Next-Generation Sequencing in Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Next-Generation Sequencing in Oncology Conference 2027 — FAQs
What is the Next-Generation Sequencing in Oncology track at CIOC 2027?
The Next-Generation Sequencing in Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Next-Generation Sequencing in Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Next-Generation Sequencing in Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Next-Generation Sequencing in Oncology are all welcome — whether presenting or attending.
Can I present my research in the Next-Generation Sequencing in Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Next-Generation Sequencing in Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Next-Generation Sequencing in Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.